MNG196
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
6 twins match this tumor's tissue · 4 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | MNG812 | — | — | 0.818 |
| 2 | MNG361 | — | — | 0.804 |
| 3 | MDT-AP-3307 | Med | Medulloblastoma | 0.800 |
| 4 | MNG70 | — | — | 0.796 |
| 5 | MNG1042 | — | — | 0.795 |
| 6 | MNG1222 | — | — | 0.794 |
| 7 | SRR9879265 | — | cohortMD1 | 0.791 |
| 8 | MDT-AP-3288 | Med | Medulloblastoma | 0.790 |
| 9 | SJEPD030854_D1.RNA-Seq | EPN | Posterior Fossa EPN | 0.783 |
| 10 | SJEPD030743_D1.RNA-Seq | EPN | Posterior Fossa EPN | 0.778 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 22 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| E2F_TARGETS | 0.377 | Inavolisib | — uncovered |
| MITOTIC_SPINDLE | 0.357 | Inavolisib | — uncovered |
| G2M_CHECKPOINT | 0.325 | Inavolisib | — uncovered |
| UV_RESPONSE_DN | 0.243 | Inavolisib | — uncovered |
| PROTEIN_SECRETION | 0.242 | Remibrutinib | — uncovered |
| ADIPOGENESIS | 0.218 | Inavolisib | — uncovered |
| DNA_REPAIR | 0.214 | Idelalisib | — uncovered |
| TGF_BETA_SIGNALING | 0.173 | Inavolisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.165 | Idelalisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.164 | Inavolisib | — uncovered |
| PEROXISOME | 0.163 | Idelalisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.146 | Remibrutinib | — uncovered |
| INTERFERON_ALPHA_RESPONSE | 0.141 | Inavolisib | — uncovered |
| NOTCH_SIGNALING | 0.122 | Inavolisib | — uncovered |
| MYC_TARGETS_V2 | 0.117 | Idelalisib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.089 | Inavolisib | — uncovered |
| FATTY_ACID_METABOLISM | 0.077 | Inavolisib | — uncovered |
| MYC_TARGETS_V1 | 0.052 | Inavolisib | — uncovered |
| HEDGEHOG_SIGNALING | 0.049 | Inavolisib | — uncovered |
| BILE_ACID_METABOLISM | 0.043 | Inavolisib | — uncovered |